(VIANEWS) – Shares of TherapeuticsMD (NASDAQ: TXMD) fell 5.88% to $0.32 at 10:48 EST on Friday, after two consecutive sessions in a row of losses. NASDAQ is falling 1.41% to $13,954.62, after three consecutive sessions in a row of losses. This seems, up until now, an all-around negative trend trading session today.

TherapeuticsMD’s last close was $0.34, 87.64% below its 52-week high of $2.75.


Today’s last reported volume for TherapeuticsMD is 1028231 which is 83.29% below its average volume of 6154453.

TherapeuticsMD’s Sales

TherapeuticsMD’s sales growth is 33.7% for the current quarter and 29.3% for the next. The company’s growth estimates for the present quarter and the next is 16.7% and 40%, respectively.

TherapeuticsMD’s Revenue

Year-on-year quarterly revenue growth grew by 114.9%, now sitting on 84.79M for the twelve trailing months.


TherapeuticsMD’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.18%, a negative 0.94%, and a positive 5.78%, respectively.

TherapeuticsMD’s highest amplitude of average volatility was 3.53% (last week), 4.48% (last month), and 5.78% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

TherapeuticsMD’s stock is considered to be oversold (<=20).

TherapeuticsMD’s Stock Yearly Top and Bottom Value

TherapeuticsMD’s stock is valued at $0.32 at 10:48 EST, way below its 52-week low of $0.37.

TherapeuticsMD’s Moving Average

TherapeuticsMD’s worth is way under its 50-day moving average of $0.66 and way under its 200-day moving average of $1.00.

More news about TherapeuticsMD (TXMD).


Please enter your comment!
Please enter your name here